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    The isologous bone marrow which had been kept in glycerol-Tyrode's solution at —80°C 
 as long as 270 days protected well the lethally gamma-irradiated mice as well as the fresh 
 IBM transplantation did, as far as 5 million of nucleated cells were injected. 
    The homologous bone marrow preserved as long as 90 days gave higher 21 days survival 
 rates than those in the fresh HBM transplantation, as far as 5 million of nucleated cells 
 were injected, and furthermore postponed the development of the secondary diseases as 
 compared to the fresh HBM transplantation. The HBM which had been preserved more 
 than 90 days and given in dose of 5 million nucleated cells, however, could not protect the 
 lethally irradiated mice.When the number of the nucleated cells which were preserved 
 and transplanted was increased up to 10 million, good early survival rates were observed in 
 120 days and 180 days preserved HBM transplantation. The supposed reasons for this 
 favorable effect by freezing were discussed. 
                          INTRODUCTION 
   The long term preservation of bone marrow cells is essentially necessary 
for the clinical application of bone marrow transplantation. Since Polge" reported 
the successful preservation of living cells with glycerol as a preservative addi-
tive, the application of this method to bone marrow cell preservation has been 
developed using glycerol in the solid carbon dioxide or liquid nitrogen, and the 
preserved isologous as well as homologous bone marrow transplantation in 
lethally irradiated mammals has been studied by many workers2",". On the 
other hand, there have been some reports concerning tissue transplantation 
suggesting that there is a possibility that the cooling or freezing might facilitate 
taking of the homologous tissue graft" , but there has been no report concern-
ing the homologous bone marrow transplantation in lethally irradiated mice 
which was carried out from such a view-point, so far. These are the reasons 
why this type of experiments was undertaken. 
                     MATERIALS AND METHODS 
   Dd/s strain mice supplied from the Kyoto University Animal Center were 
 * 4"if, =rk, i -i 1-' 7`f l*A. Il/fV Tr -
                            (56)
       Bone Marrow Treatment of Mice Lethally Irradiated  with Gamma-Rays (V) 
used as recipients and the isologous bone marrow (IBM) donors. Na2 mice 
were used as the homologous bone marrow (HBM) donors. They were two to 
two and a half months old mice weighing approximately 20 g at the time of 
experiments. The sexes of the donors and recipients were identical. The 
animals were fed whole wheat and dried fish, and were given tap water ad 
libitum. 
   All mice were irradiated in the Co`i0 gamma-irradiation facility belonging to 
the Institute for Chemical Research of Kyoto University". The procedure for 
transplantation was described previouslys'9''. 
   In order to preserve the freezed bone marrow cell suspensions, 15% glycerol-
Tyrode's solution was used as one of the protective additives according to Tran107. 
   The sealed glass ampules containing an aliquot of the suspension of bone 
marrow cells were freezed and kept at —80°C with ethanol-dry ice system in 
the vacuum bottle. The cooling rate was approximately 1°C per minute untill 
the temperature in the bath reached —20°C and then not beyond 10°C per minute 
untill —80°C. The ampules were immersed in warm water at 37°C for thawing, 
and then the bone marrow cell suspension was immediately used for the trans-
plantation. 
                     RESULTS AND DISCUSSIONS 
   1. Preserved IBM Transplantation
   The results are shown in Table 1 and Fig. 1. In this Table, the control 
group consisted of the mice lethally irradiated with 900 r gamma-rays without 
bone marrow treatment and the fresh group means the mice lethally irradiated 
and treated with the fresh IBM. The number of the injected nucleated cells 
was 5 million. When the bone marrow cell suspension was preserved with 
ethanol-dry ice at —80°C as long as 270 days, the percentage of eosin-staining 
      Table 1. Survival rate of gamma-irradiated mice treated with preserved IBM. 
                      Percent Number of survival(at days)% Survival 
                          ----- 
 Preservation No. of staining Number of irradiated(at days) 
  period experiment with eosin ------------"---------------                  (%) 
14 21 30 60 90 21 30 60 90 
 Control10 — 1/49 0/49 — — — 0 — — — 
 Fresh29 14/19 13/19 13/19 13/19 13/19 68 68 68 68 
  10 days2 18 16/20 16/20 15/20 13/20 13/20 80 75 65 65 
  20 days2 21 17/24 16/24 16/24 16/24 16/24 65 65 65 65 
  30 days1 21 10/17 10/17 10/17 10/17 10/17 58 58 58 58 
  60 days1 27 7/8 7/8 6/8 6/8 6/887 75 75 75 
  90 days1 33 6/10 6/10 6/10 6/10 5/10 60 60 50 50 
  120 days2 39 12/13 12/13 11/13 10/13 10/13 92 84 84 84 
  150 days2 58 12/14 10/14 10/14 6/14 6/14 71 71 42 42 
  180 days3 60 12/16 11/16 11/16 10/16 10/16 68 68 62 62 
  270 days2 48 12/15 10/14 10/14 10/14 10/14 71 71 71 71 
   The number of nucleated cells injected was 5 million which was preserved at —80°C in 
159' glycerol-Tyrode's solution. 
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      Fig. 1. Changes of percent survival in mice irradiated lethally and treated with 
        preserved isologous bone marrow at —80°C. 
        The nucleated cell number was 5 million. 
        Preservation was carried out in 15% glycerol-Tyrode's solution for 10, 20, 30, 
       60, 120, 150, 180 and 270 days. 
cells, which was thought to show the viability of the preserved cells, was 48%, 
while that of the fresh, non-preserved bone marrow cells was 9% in an average 
of 19 mice bone marrow cell preservation. It was found, however, that the 
survival rates at 21 days were 58 to 92% in every group. This means that the 
preservation of the freezed IBM as long as 270 days did not change the effec-
tiveness of the protection against the irradiation under the lethal dosis. 
   Body weight (decreased up to approximately 90% of the pre-irradiation level 
following the bone marrow transplantation in lethally irradiated mice, and it 
took 12 days in mice treated with 90 days preserved IBM, 19 days with 180 days 
preserved, 18 days with 270 days preserved, untill the body weight recovered to 
the pre-irradiation level, while it usually took 15 days is mice treated with IBM 
without preservation. Namely, a retarded recovery of body weight for 3 to 4 
days was found in mice -treated with the preserved IBM, as compared to mice 
treated with the fresh IBM. On the other hand, the most decreased body weight 
was found 6 to 10 days after the irradiation, and there was no difference in 
these days between the preserved IBM group and the fresh IBM group. These 
results show that such a condition of the freezed preservation could give the 
effect of treatment almost similar to that of the fresh IBM in lethally irradiated 
mice. 
   As to the freezing at 0° to 4°C, Ursoll' reported that the viability of the 
cells was lost in 6 days under this condition. Luyet"' as well as Merryman" 
claimed that Tyrode's solution with 15% glycerol as a protective additive could 
protect the cells from the intracellular formation of the ice crystals, and 
Bender"' also reported that the bone marrow cells preserved for one year at 
—80°C had still their viability. Our results also support these report. Further 
investigations of hematological and pathological findings in details will be 
( 58 )
       Bone Marrow Treatment of Mice Lethally Irradiated with Gamma-Ray (V) 
reported  elswherew. 
   2. Preserved HBM Transplantation 
   The survival rates of Dds/S mice lethally irradiated with 900 r gamma-rays 
which were treated with the preserved HBM of Na2 donor mice are shown in 
Table 2 and Fig. 2, in which the number of the nucleated cells was 5 million. 
In this type of experiment, the survival rates at 21 days were 31%, 44% and 
50% in 30 days, 60 days and 90 days preserved HBM transplantation, respec-
tively. It should be noted that the early survival rates in the transplantation 
of the preserved HBM as long as 90 days gave better results than those in the 
fresh HBM transplantation group, although the number of the non-viable cells 
measured with the eosin-staining method increased from 10% in fresh bone 
marrow cell suspension to 25% in 90 days preserved bone marrow. The delayed 
death rates increased from 30 days to 60 days after the preserved HBM trans-
plantation equally in every group, while those in the fresh HBM transplantation 
group were increasing till 90 days after the transplantation. The survival 
percentages, however, were higher in the preserved group than in the fresh 
group. 
      Table 2. Survival rate of gamma-irradiated mice treated with preserved HBM. 
                   Percent Number--------ofsurvival5.Survival                                    ---_..-(at d ys) 
  Preserved No. of staining Number of irradiated(at days) 
    period experiment with eosin —------ 
(4) 14 21 30 60 90 21 30 60 90 
 Control10 — 1/49 0/49 — — — 0 — — — 
 Fresh5 10 27/65 17/65 11/64 6/60 3/60 25 17 10 5 
  (without preservation) 
  30 days 2 13 8/16 5/16 3/16 2/16 2/16 31 18 12 12 
  60 days 4 17 18/25 11/25 8/25 6/25 5/25 44 32 24 20 
  90 days 2 25 6/10 5/10 4/10 2/10 2/10 50 40 20 20 
 120 days 2 26 1/13 0/13 — —0 — — — 
 150 days 1 33 0/8 0/8 — — — 0 — — — 
 180 days 2 51 3/14 0/14 — — — 0 — — — 
   The number of nucleated cells injected was 5 million which was preserved at —80°C in 
15% glycorol-Tyrode's solution. 
   Therefore, this suggests the possibility that the preservation at —80°C of 
HBM in 15% glycerol-Tyrode's solution makes the recipient mice take easily and 
postpones the development of the secondary diseases. On the other hand, 
HBM transplantation preserved longer than 120 days showed no protection 
effect. This observation was also confirmed by the body weight change follow-
ing the transplantation. As reported previously"' body weight change in HBM 
transplantation can be classified into three types, namely, type a) being the 
almost same change as that of the irradiated and non-treated controls, type 
b) being the same as that of mice treated with IBM and type c) showing a 
rather slight degree of initial weight loss followed by a tendency to increase 
by 15 or 20 days and then followed by rapid decreases. The HBM transplanta-
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    Fig. 2. Changes of percent survival in mice irradiated lethally and treated with 
       preserved homologous bone marrow at —80°C. 
      The nucleated cell number was 5 or 10 million. 
      Preservation was carried out in 15% glycerol-Tyrode's solution for 30, 60, 90, 
      120, 150 and 180 days. 
    Table 3. Survival rate of gamma-irradiated mice treated with preserved HBM. 
                        PercentNumber of survival (at days) %~ Survival 
Preservation No. of staining Number of irradiated(at days) 
 period experiment with eosin  (%) 14 21 30 60 90 
21 30 60 90 
Control10 —1/49 0/49 — — — 0 — — — 
Fresh1 108/16 7/16 7/16 7/16 6/16 43 43 43 37 
 30 days3 1317/20 7/20 4/20 4/20 1/20 35 20 20 5 
 60 days1 176/7 5/7 4/7 3/7 2/7 71 57 28 28 
90 days2 252/15 0/15 — — — 0 — — — 
120 days2 2612/15 9/15 7/15 6/15 4/15 60 46 40 26 
150 days3 339/26 1/26 1/26 1/26 1/26 3 3 3 3 
180 days2 519/11 5/11 5/11 4/11 3/11 45 45 36 26 
 The number of nucleated cells was 10 million which was preserved at —80°C in 15% 
 glycerol-Tyrode's solution. 
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      Fig. 3. Body weight changes in mice irradiated lethally and treated with pre-
        served isologous as well as homologous bone marrow. 
        The nucleated cell number was 5 million.
        Preservation was carried out at —80°C in 15% glycerol-Tyrode's solution for 
        60 days. 
tion preserved longer than 120 days resulted in type c) body weight changes as 
shown in Fig. 3. Table 3 and Fig. 2 show the result when 10 million nucleated 
HBM cells were used. In this type of experiment, the survival rates at 21 days 
were 60% and 45% in 120 days and 180 days preserved HBM transplantation, 
respectively. The early survival rates in the preserved HBM transplantation 
as long as 180 days also gave better results so far than those in the fresh 
group, although those in 90 days and 150 days preserved HBM transplantation 
were quite disappointing. On the other hand, the delayed death rates showed 
almost the same in every group. It appeares that the preserved HBM trans-
plantation also makes the recipient mice take easily as compared to HBM 
transplantation without preservation. As to the development of the secondary 
disease, however, conclusive results could not be obtained in this expriment. 
Mathe et al.1e claimed that there is a difference between the immunnologi-
cally competent cells and hematopoietic myeloid-restoring cells as to the sensi-
tivities against the change of the temperature. This idea appears to support 
our observations that freezing facilitated taking and postpond the development 
of the secondary diseases. The further observations on this type of experi-
ments and on the use of dimethylsulfoxide as a protective additive are now in 
progress and will be reported in near future". 
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